FRES

Fresh2 Group Limited (FRES) | Rumor.io

Fresh2 Group

FRES

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)97%

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)0

Social

What share of all stock conversation is about FRES?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% new	0% +0

Sep 22

$FRES has surpassed 100k market cap and includes over 160 holders, with a current market cap of around 106K.
The asset is experiencing momentum, with a 2.09x pump and 117 holders, and is being considered for potential growth.
The community is actively discussing $FRES, with some members questioning its legitimacy as a meme or a potentially valuable investment.

Generated by AI

Sentiment

Of the messages about FRES that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	97.7% -1.03
Bearish	—	—	—	2.3% +1.03

Bullish· Jun 4

$FRES is showing strong volume and shares are being absorbed off key levels, making it an attractive trade.
Fresh2 Group Limited is experiencing a significant pre-market rally, up 37.39% and 12.11% respectively, indicating strong investor interest.
$FRES has a low China float and high insider ownership, with a solid setup for a potential further run, but also a warning of a possible drop if the price gets too parabolic.

Bearish· Aug 22

$FRES is expected to drop to $0.45, which could result in significant losses for investors.
The stock has a history of disappointing its holders, with one investor averaging down for a year only to be left far from breaking even.
A retest of the $0.20 level is possible, which could lead to further selling pressure and a potential drop to $0.24.

Generated by AI

Topics

Of the messages about FRES that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Technical Analysis	—	—	—	0.11%
Macro	—	—	—	50.09%
Earnings	—	—	—	0%
Controversies	—	—	—	0%
Announcements	—	—	—	1.24%
Analysts	—	—	—	48.56%

Announcements· Jun 18

Fresh2 Group Limited's ($FRES) subsidiary, AnPac Bio, has been granted its first disease treatment patent by the United States Patent and Trademark Office.
The patent covers novel medical devices for disease detection and treatment applications, with 25 claims, and is the 21st patent granted to AnPac Bio in the U.S.
AnPac Bio's newly launched cancer treatment joint venture has secured over $4 million in capital contributions from multiple funding sources.

Technical Analysis· Jun 18

$FRES is in a wedge with stable resistance and rising support, indicating a potential move up or down.
The stock needs to break above $5.28 to continue the uptrend, and has shown a strong support base around $4-$5.
The 2-year chart shows a classic "Descending triangle" pattern, which may indicate a bearish trend, but the author is not convinced it spells gloom for the stock.

Generated by AI

Community

Of the messages about FRES, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	100%	5.24%
Newcomers	—	—	0%	94.76%

Also Discussed

Investors talking about FRES also mention

#	Name	Attention
1	AIH - Aesthetic Medical International Holdings Group Limited	——
2	TScan Therapeutics, Inc.TCRX	0%0
3	Exagen Inc.XGN	0%new
4	Skillful Craftsman Education Technology LimitedEDTK	0%0
5	WHLM - Wilhelmina International, Inc.	——
6	Shuttle Pharmaceuticals Holdings, Inc.SHPH	0%0
7	Kiora Pharmaceuticals Inc.KPRX	0%0
8	AHI - Advanced Health Intelligence Ltd	——
9	Medalist Diversified, Inc.MDRR	0%0
10	Ultralife CorporationULBI	0%0

Fresh2 Group Limited

Location

Social

What share of all stock conversation is about FRES?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% new	0% +0

Sep 22

$FRES has surpassed 100k market cap and includes over 160 holders, with a current market cap of around 106K.
The asset is experiencing momentum, with a 2.09x pump and 117 holders, and is being considered for potential growth.
The community is actively discussing $FRES, with some members questioning its legitimacy as a meme or a potentially valuable investment.

Generated by AI

Sentiment

Of the messages about FRES that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	97.7% -1.03
Bearish	—	—	—	2.3% +1.03

Bullish· Jun 4

$FRES is showing strong volume and shares are being absorbed off key levels, making it an attractive trade.
Fresh2 Group Limited is experiencing a significant pre-market rally, up 37.39% and 12.11% respectively, indicating strong investor interest.
$FRES has a low China float and high insider ownership, with a solid setup for a potential further run, but also a warning of a possible drop if the price gets too parabolic.

Bearish· Aug 22

$FRES is expected to drop to $0.45, which could result in significant losses for investors.
The stock has a history of disappointing its holders, with one investor averaging down for a year only to be left far from breaking even.
A retest of the $0.20 level is possible, which could lead to further selling pressure and a potential drop to $0.24.

Generated by AI

Topics

Of the messages about FRES that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Technical Analysis	—	—	—	0.11%
Macro	—	—	—	50.09%
Earnings	—	—	—	0%
Controversies	—	—	—	0%
Announcements	—	—	—	1.24%
Analysts	—	—	—	48.56%

Announcements· Jun 18

Fresh2 Group Limited's ($FRES) subsidiary, AnPac Bio, has been granted its first disease treatment patent by the United States Patent and Trademark Office.
The patent covers novel medical devices for disease detection and treatment applications, with 25 claims, and is the 21st patent granted to AnPac Bio in the U.S.
AnPac Bio's newly launched cancer treatment joint venture has secured over $4 million in capital contributions from multiple funding sources.

Technical Analysis· Jun 18

$FRES is in a wedge with stable resistance and rising support, indicating a potential move up or down.
The stock needs to break above $5.28 to continue the uptrend, and has shown a strong support base around $4-$5.
The 2-year chart shows a classic "Descending triangle" pattern, which may indicate a bearish trend, but the author is not convinced it spells gloom for the stock.

Generated by AI

Community

Of the messages about FRES, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	100%	5.24%
Newcomers	—	—	0%	94.76%

Fresh2 Group

Social

Sep 22

Sentiment

Bullish· Jun 4

Bearish· Aug 22

Topics

Announcements· Jun 18

Technical Analysis· Jun 18

Community

Also Discussed

Fresh2 Group Limited

Company Information

Location

Social

Sep 22

Sentiment

Bullish· Jun 4

Bearish· Aug 22

Topics

Announcements· Jun 18

Technical Analysis· Jun 18

Community

Also Discussed